TD Asset Management Inc grew its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC – Free Report) by 2.9% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 388,005 shares of the company’s stock after purchasing an additional 10,962 shares during the quarter. TD Asset Management Inc owned about 0.09% of GE HealthCare Technologies worth $31,824,000 at the end of the most recent quarter.
Several other institutional investors have also recently made changes to their positions in the stock. Western Wealth Management LLC increased its position in shares of GE HealthCare Technologies by 2.4% during the 4th quarter. Western Wealth Management LLC now owns 5,240 shares of the company’s stock worth $430,000 after purchasing an additional 125 shares during the last quarter. United Community Bank increased its position in shares of GE HealthCare Technologies by 10.2% during the 4th quarter. United Community Bank now owns 1,410 shares of the company’s stock worth $116,000 after purchasing an additional 130 shares during the last quarter. Thoma Capital Management LLC increased its position in shares of GE HealthCare Technologies by 1.4% during the 4th quarter. Thoma Capital Management LLC now owns 9,918 shares of the company’s stock worth $814,000 after purchasing an additional 136 shares during the last quarter. Colonial Trust Advisors increased its position in shares of GE HealthCare Technologies by 11.1% during the 3rd quarter. Colonial Trust Advisors now owns 1,391 shares of the company’s stock worth $104,000 after purchasing an additional 139 shares during the last quarter. Finally, Norinchukin Bank The increased its position in shares of GE HealthCare Technologies by 0.4% during the 3rd quarter. Norinchukin Bank The now owns 38,913 shares of the company’s stock worth $2,922,000 after purchasing an additional 149 shares during the last quarter. Institutional investors and hedge funds own 82.06% of the company’s stock.
GE HealthCare Technologies Stock Up 1.3%
GEHC stock opened at $64.67 on Friday. The company has a current ratio of 1.22, a quick ratio of 0.95 and a debt-to-equity ratio of 0.95. The firm has a market capitalization of $29.42 billion, a PE ratio of 15.47, a PEG ratio of 1.46 and a beta of 0.74. GE HealthCare Technologies Inc. has a 1-year low of $58.75 and a 1-year high of $89.77. The business’s 50 day simple moving average is $66.89 and its 200 day simple moving average is $75.49.
Analysts Set New Price Targets
GEHC has been the topic of several recent analyst reports. Piper Sandler lowered their price target on GE HealthCare Technologies from $88.00 to $74.00 in a research report on Thursday, April 30th. Citigroup lowered their price target on GE HealthCare Technologies from $80.00 to $65.00 and set a “neutral” rating on the stock in a research report on Thursday, April 30th. Wall Street Zen lowered GE HealthCare Technologies from a “buy” rating to a “hold” rating in a research report on Saturday, March 21st. HSBC lowered their price target on GE HealthCare Technologies from $100.00 to $90.00 in a research report on Thursday, April 30th. Finally, Mizuho decreased their target price on GE HealthCare Technologies from $90.00 to $80.00 in a report on Thursday, April 30th. Nine investment analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $80.21.
Get Our Latest Stock Report on GEHC
Insider Buying and Selling at GE HealthCare Technologies
In other news, CEO Peter J. Arduini acquired 4,169 shares of the firm’s stock in a transaction on Thursday, April 30th. The shares were purchased at an average cost of $59.92 per share, with a total value of $249,806.48. Following the acquisition, the chief executive officer directly owned 259,424 shares in the company, valued at $15,544,686.08. This represents a 1.63% increase in their position. The purchase was disclosed in a document filed with the SEC, which is accessible through this link. Also, insider Frank R. Jimenez acquired 1,750 shares of the stock in a transaction on Thursday, April 30th. The shares were purchased at an average price of $60.45 per share, for a total transaction of $105,787.50. Following the transaction, the insider directly owned 93,932 shares in the company, valued at approximately $5,678,189.40. This trade represents a 1.90% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Insiders acquired 21,847 shares of company stock worth $1,361,355 in the last three months. 0.36% of the stock is owned by insiders.
About GE HealthCare Technologies
GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.
In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.
See Also
- Five stocks we like better than GE HealthCare Technologies
- Samsara Just Answered The AI Question—Is Wall Street Ready To Listen?
- IREN’s 800MW Bet Flips the AI Power Switch
- CrowdStrike Earnings Beat Sparks Selloff—Buy the Dip?
- Tesla’s EV Rebound Leaves Rivian and Lucid Facing a Tougher Investor Test
Receive News & Ratings for GE HealthCare Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GE HealthCare Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
